Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease

Annals of Internal Medicine

Volumn 125, Issue 1, 1996, Pages 19-25

  Winkelmann, Bernhard R ^a,b   Nauck, Markus ^d   Klein, Bärbel ^a   Russ, Andreas P ^c   Böhm, Bernhard O ^g   Siekmeier, Rüdiger ^e   Ihnken, Kai ^f   Verho, Matti ^b   Groß, Werner ^a   März, Winfried ^d  

^a GOETHE UNIVERSITY   (Germany)

^b SANOFI   (France)

^c Wellcome CRC Institute   (United Kingdom)

^d UNIVERSITY OF FREIBURG   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f Carl Gustav Carus Tech University ^*  (United States)

^g UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; ENZYME ACTIVITY; GENE DELETION; GENE FREQUENCY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0030317949     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-1-199607010-00004     Document Type: Article

References (44)

1. Soubrier F, Hubert C, Testut P, Nadaud S, Alhenc-Gelas F, Corvol P. Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene. J Hypertens. 1993;11:471-6.
2. Skeggs LT Jr, Kahn JR, Shumway NP. The preparation and function of the hypertensin-converting enzyme. J Exp Med. 1957;103:295-9.
3. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-6.
4. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197-205.
5. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Mature. 1992;359:641-4.
6. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TIA, the Copenhagen City Heart Study Group. The angiotensin-converting-enzyme gene polymorphism fails to predict coronary heart disease in a case-cohort study of 7300 individuals [Abstract], Circulation. 1996;92(Suppl 1):800.
7. Leatham E, Barley J, Redwood S, Hussein W, Carter N, Jeffery S, et al. Angiotensin-1 converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens. 1994;8:635-8.
8. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet. 1993;44:292-7
9. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-11.
10. Mattu RK, Needham EW, Galton DJ, Frangos E, Clark AJ, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation. 1995;91:270-4.
11. Gardemann A, Weiß T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, et al. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation. 1995;92:2795-9.
12. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis. 1995;112:137-43.
13. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995;91:2120-4.
14. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 1995;345:1600-3.
15. WHO Study Group on Diabetes Mellitus. Diabetes mellitus. Geneva: World Health Organization: 1985.
16. Austen WG, Edwards JE, Frye RU Gensini CG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975;51(Suppl):5-40.
17. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
18. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl. 1993;3:120-1.
19. 2 precipitation and a quantitative lipoprotein electrophoresis assay. Clin Chim Acta. 1986;160:1-18.
20. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens [Rapid coagulation method for determination of fibrinogen]. Acta Haematol. 1957;17:237-46.
21. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA. 1994;91:3662-5.
22. Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, et al. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J. 1995;74:584-91.
23. Beohar N, Damaraju S, Prather A, Yu QT, Raizner A, Kleiman NS, et al. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med. 1995;43:275-80.
24. Payne MN, McDonald F, Murray RG, Bartlett WA, Jones AF, Beattie JM. Plasma angiotensin-converting enzyme activity and carotid wall thickening [Letter]. Circulation. 1994;90:2566-8.
25. Ahnve S, Flodin T, Berglund L, Eggertsen G, Sylven C. Angiotensin converting enzyme gene polymorphism in acute myocardial infarction patients [Abstract]. J Am Coll Cardiol. 1995;26:277.
26. Gläser C, Rauchhaus M, Handschug K, Teichmann W, Holtz J. Angiotensin converting enzyme genotypes in patients elected for percutaneous transluminal catheter angioplasty [Abstract]. Circulation. 1994;90(Suppl 1):364.
27. Robitaille NM, Bogaty P, Asselin MJ, Genest M, Labbé L, Lefez C, et al. Genotype distribution of the angiotensin converting enzyme insertion/ deletion (I/D) polymorphism differs among young cardiac and young healthy Canadian subjects [Abstract] Circulation. 1994;90(Suppl 1):110.
28. Wesolowska EB, Lussier-Cacan S, Solymoss C, Davignon J, Genest J Jr. Angiotensin converting enzyme polymorphism in premature CAD and controls in French Canadians: lack of association with CAD and risk factors [Abstract]. In: Abstracts Submitted to the Council on Arteriosclerosis for the 67th Scientific Sessions of the American Heart Association (but Not Presented). Dallas: American Heart Association; 1994:78.
29. Jamieson A, Murdoch D, Kesson E, Inglis GC, Campbell M, Cooke A, et al. ACE genotype is not risk factor for myocardial infarction under 45 years of age [Abstract]. In: Abstracts Submitted to the Council on Arteriosclerosis for the 67th Scientific Sessions of the American Heart Association (but Not Presented). Dallas: American Heart Association; 1994:120.
30. Moussard C, Vuillemenot A, Henry JC, Bassand JP. Polymorphism in the angiotensin I-converting enzyme and apolipoprotein E genes and restenosis after coronary angioplasty in men [Abstract]. Eur Heart J. 1995;16(Suppl):370.
31. Miettinen HE, Korpela K, Hämäläinen L, Kontula K. Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet. 1994;94:189-92.
32. Bolibar I, Thompson SG, von Eckardstein A, Sandkamp M, Assmann G. Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Strong, independent, and comprehensive. ECAT Angina Pectoris Study Group. Arterioscler Thromb Vasc Biol. 1995;15:1035-42.
33. Assmann G, Schulte H. Identification of individuals at high risk for myocardial infarction. Atherosclerosis. 1994;110(Suppl):11-21.
34. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-74.
35. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, et al. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension. 1993;21:455-60.
36. Lachurié ML, Azizi M, Guyene TT, Alhenc-Gelas F, Ménard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation. 1995;91:2933-42
37. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, et al. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res. 1993;72:312-8.
38. Huang H, Arnal JF, Llorens-Cortes C, Challah M, Alhenc-Gelas F, Corvol P, et al. Discrepancy between plasma and lung angiotesin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction. Circ Res. 1994;75:454-61.
39. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in human heart. J Biol Chem. 1990;265:22348-57.
40. Okamura T, Okunishi H, Ayajiki T, Toda N. Conversion of angiotensin I to angiotensin II in dog isolated renal artery: role of two different angiotensin II-generating enzymes. J Cardiovasc Pharmacol. 1990;15:353-9.
41. Morris BJ, Zee RY, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest. 1994;94:1085-9.
42. Andersson B, Sylvén C. The DD genotype of the ACE-gene is associated with increased mortality in idiopathic heart failure [Abstract]. Eur Heart J. 1995;16(Suppl):113.
43. Schächter F, Faure-Delanef L, Gúenot F, Rouger H, Froguel P, Lesueur-Ginot L, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29-32.
44. Marshall HW, Morrison LC, Wu LL, Anderson JL, Corneli PS, Stauffer DM, et al. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study. Circulation. 1994;89:567-77.